Milrinone is a phosphodiesterase inhibitor, a cardiotonic drug with positive inotropic and vasodilating effects, which can be used to treat acute or chronic refractory congestive heart failure.
Millinone is a cardiotropic drug, belonging to phosphodiesterase inhibitors. By inhibiting phosphodiesterase, the drug can increase the concentration of cyclic adenosine phosphate and calcium in cardiomyocytes, thereby effectively strengthening myocardial contractility and increasing cardiac output, so as to exert positive muscle strength. In addition, Milrinone can also play a vasodilator role by directly acting on the small arteries.
milrinone supports ventricular functioning of the heart by decreasing the degradation of cAMP and thus increasing phosphorylation levels of many components in the heart that contribute to contractility and heart rate. Milrinone use following cardiac surgery has been under some debate because of the potential increase risk of postoperative atrial arrhythmias. However, in the short term milrinone has been deemed beneficial to those experiencing heart failure and an effective therapy to maintain heart function following cardiac surgeries. There is no evidence of any long term beneficial effects on survival.
Milrinone, is a medication used in patients who have heart failure. It is a phosphodiesterase 3 inhibitor that works to increase the heart's contractility and decrease pulmonary vascular resistance. Milrinone also works to vasodilate which helps alleviate increased pressures (afterload) on the heart, thus improving its pumping action. While it has been used in people with heart failure for many years, recent studies suggest that milrinone may exhibit some negative side effects that have caused some debate about its use clinically.
Overall, milrinone supports ventricular functioning of the heart by decreasing the degradation of cAMP and thus increasing phosphorylation levels of many components in the heart that contribute to contractility and heart rate. Milrinone use following cardiac surgery has been under some debate because of the potential increase risk of postoperative atrial arrhythmias. However, in the short term milrinone has been deemed beneficial to those experiencing heart failure and an effective therapy to maintain heart function following cardiac surgeries. There is no evidence of any long term beneficial effects on survival.
اسان وٽ ڪيترائي اعلي معيار جا ڪارخانا آهن جن سان گڏ تعاون، جيڪو توهان کي اعلي معيار جي شين ۽ مقابلي واري قيمتن سان مهيا ڪري سگهي ٿو. ۽ اسان وڏي پئماني تي خريداري لاءِ رعايتون پڻ ڏئي سگھون ٿا. ۽ اسان ڪيترن ئي پروفيشنل فريٽ فارورڊنگ ڪمپنين سان تعاون ڪريون ٿا، پراڊڪٽس کي محفوظ ۽ آسانيءَ سان توهان جي هٿن تائين پهچائي سگهون ٿا. پهچائڻ وقت جي باري ۾ آهي 3-20 ڏينهن جي ادائيگي جي تصديق کان پوء.
تجزيو
|
تفصيل
|
نتيجو
|
Test method
|
Physical Description
|
|
|
|
ظاهر
|
White Powder
|
White Powder |
Visual
|
گند
|
Characteristic
|
Characteristic
|
Organoleptic
|
Particle size
|
90% pass 80 mesh
|
90% pass 80 mesh
|
80 Mesh Screen
|
Chemical Tests
|
|
|
|
Assay (Lutein)
|
99%
|
90.15%
|
HPLC
|
Loss on drying
|
5.0% Max
|
1.82%
|
5g/105ºC/2hrs
|
Ash Contents
|
5.0% Max
|
1.12%
|
2g/525ºC/3hrs
|
Residual Solvents
|
50.0 ppm, Only Ethanol
|
<30.0 ppm
|
/
|
Heavy metals
|
5.0 ppm Max
|
<3.0 ppm
|
AAS
|
Lead
|
3.0 ppm Max
|
<1.0 ppm
|
AAS
|
Arsenic
|
3.0 ppm Max
|
<1.0 ppm
|
AAS
|
Microbiology Control
|
|
|
|
Total Bacteria Count
|
1,000cfu/g Max
|
<280cfu/g
|
AOAC
|
Yeast & Mold
|
100cfu/g Max
|
<10cfu/g
|
AOAC
|
Coliform
|
30.0 MPN/g Max
|
<3.0 MPN/g
|
AOAC
|
نتيجو
|
Complies with the standards.
|
||
General Status
|
Non-GMO, ISO Certificated.
|
Milrinone is a PDE3 (phosphodiesterase 3) inhibitor that exhibits vasodilator and positive inotropic effects. Milrinone's positive inotropic activity can be inhibited by carbachol (sc-202092). Research indicates that Milrinone can increase platelets and enhance cAMP levels. Milrinone is an inhibitor of PDE3A and PDE3B.
Milrinone, commonly known and marketed as the drug Primacor, is a medication used in patients suffering from heart failure. Milrinone is a phosphodiesterase 3 inhibitor that works to increase the heart's contractility. Milrinone also works to vasodilate vessels which helps alleviate increased pressures (afterload) on the heart, thus improving its pumping action. Milrinone has been used in those suffering from heart failure for many years.
1. ڇا توهان هڪ ڪارخانو يا هڪ واپاري ڪمپني آهي؟
اسان صنعت ۽ واپار کي ضم ڪرڻ واري ڪمپني آهيون، هڪ اسٽاپ سروس فراهم ڪري رهيا آهيون.OEM قبول ڪري سگهجي ٿو.
2. ڇا توهان نموني مهيا ڪندا آهيو؟ ڇا اهو مفت يا اضافي آهي؟
مفت نموني. نموني جي مال جي فيس توهان جي پاسي کان ادا ڪرڻ جي ضرورت آهي.
3. ڇا توهان وٽ ڪيفيت ڪنٽرول سان لاڳاپيل سرٽيفڪيٽ آهن؟
معيار کي يقيني بڻائڻ لاء ISO 9001: 2008 سرٽيفڪيشن.
4. مون کي اقتباس حاصل ڪرڻ لاء ڇا مهيا ڪرڻ گهرجي؟
مهرباني ڪري اسان کي پروڊڪٽ جي قسم جي ڄاڻ ڏيو جنهن جي توهان کي ضرورت آهي، آرڊر جي مقدار، ايڊريس ۽ مخصوص گهرجن. ڪوٽا توهان جي حوالي سان وقت ۾ ڪئي ويندي.
5. توهان ڪهڙي قسم جي ادائگي جو طريقو پسند ڪندا آهيو؟ ڪهڙي قسم جا شرط قبول ڪيا ويا آهن؟
قبول ٿيل پهچائڻ جون شرطون: FOB، CFR، CIF، EXW؛
قبول ٿيل ادائگي جي ڪرنسي: USD؛
قبول ٿيل ادائگي جو قسم: T/T، ويسٽرن يونين؛ Paypal، واپار جي ضمانت.
ڳالهائيندڙ ٻولي: انگريزي.
مصنوعات جا زمرا